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ABSTRACT
Purpose: We sought evidence to justify undertaking population-based trachoma surveys in Timor-
Leste, believing that in the absence of such evidence, the country could be categorized as not
needing interventions to eliminate trachoma.
Methods: We undertook a systematic review of published literature on trachoma in Timor-Leste,
with results updated to 28 April 2018. We also undertook a series of clinic- and field-based
screening exercises, consisting of: (1) in October 2015, conjunctival examination of all children
attending a school in Vila, Atauro Island; (2) from 1 November 2016 to 30 April 2017, examination
for trichiasis, by specifically-trained frontline eye workers, of all individuals presenting to the
ophthalmic clinics of six referral hospitals and five district eye clinics; and (3) house-to-house case
searches in a total of 110 households, drawn from three communities that were reported by
investigators from the 2016 Rapid Assessment of Avoidable Blindness (RAAB) to include residents
with trachoma.
Results: Three RAABs (2005, 2009–2010, 2016) and two relevant published papers were identified.
The 2016 RAAB reported one female subject to have been diagnosed with trachomatous corneal
opacity. Re-examination of that individual revealed that she had ankyloblepharon, without
evidence of trichiasis or entropion. No children on Atauro Island, no clinic attendees, and no
individuals examined in the targeted house-to-house searches had any sign of trachoma.
Conclusion: Trachoma is very unlikely to be a public health problem in Timor-Leste. It would not
be appropriate to incur the costs of conducting formal population-based trachoma prevalence
surveys here.
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There is currently no commercially-available vaccine to
prevent ocular Chlamydia trachomatis infection.1,2
Prevention of blindness from trachoma3 therefore relies
on implementation of the SAFE strategy,4 which involves
surgery for trachomatous trichiasis,5 antibiotics to clear
C. trachomatis infection,6 and facial cleanliness7 and envir-
onmental improvement8 to reduce its transmission.
Whether or not these things should be implemented as
public health-level interventions for trachoma is deter-
mined by estimating the prevalence of key signs of
disease:9,10 trachomatous inflammation—follicular (TF)11
in 1–9-year-olds, and trachomatous trichiasis (TT)11 in
≥ 15-year-olds. Undertaking population-based prevalence
surveys to generate such estimates requires resources,12,13
so deciding where to do so14 is an important programmatic
step.
Trachoma is prevalent in a number of countries of
Southern and South-East Asia, Australia and the Pacific
Islands15–24 (though some aspects of the disease in the
Pacific appear to be unusual.25–29) Beyond the Western
boundary of the Pacific Ocean, between Indonesia and
Australia, lies Timor-Leste, which became a United
Nations-recognized sovereign state in 2002. Its estimated
2015 population was 1.2 million people, distributed
across the eastern half of the island of Timor, Oecusse
(an exclave on Timor Island’s northwestern side), and
the island of Atauro. Dili, the national capital, is the
CONTACT Marcelino Correia correiadr022004@yahoo.com National Eye Center, Guido Valadares National Hospital, Dili, Timor-Leste
Color versions of one or more of the figures in the article can be found online at www.tandfonline.com/iope.
OPHTHALMIC EPIDEMIOLOGY
2018, VOL. 25, NO. S1, 131–137
https://doi.org/10.1080/09286586.2018.1545037
© 2018 World Health Organization. Published with license by Taylor & Francis.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-
nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built
upon in any way. In any use of this article, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not
permitted. This notice should be preserved along with the article’s original URL.
largest city, with a 2015 population of 222,000. Atauro
had a 2015 population of 9274 people, who are consid-
ered to have the lowest socioeconomic status in the
country. Jaco, the other island included within Timor-
Leste’s territories (and the country’s easternmost land
mass) is uninhabited. The national human development
index in 2017 was 0.625, which falls in the “medium”
range.
Three factors prompted us to review the situation with
respect to trachoma in Timor-Leste. First, the country is
located close to other trachoma-endemic countries; tra-
choma clusters at various scales.30–33 Second, its popula-
tion has relatively poor access to sanitation,34 and poor
access to sanitation is associated with increased risk of
TF.35 Third, there is a current drive to complete baseline
trachoma mapping everywhere that it is justified,36 as
efforts ramp up to reach the target of global trachoma
elimination.37 We therefore looked for evidence to justify
undertaking one or more population-based trachoma
prevalence surveys here. We believed that failure to find
such evidence after diligent search would mean that
Timor-Leste could be categorized as “thought to not
require interventions (to eliminate trachoma as a public
health problem)” in the World Health Organization’s
Global Health Observatory (http://apps.who.int/gho/
data/node.main.A1645T).
Methods
Investigations were undertaken from 2015 to 2017. We
performed a systematic review plus various activities to
screen individuals for trachoma.
For the systematic review, we searched the literature,
employing three sources: (1) PubMed (https://www.ncbi.
nlm.nih.gov/pubmed/), using the search terms ((“tra-
choma*” OR “trichiasis”) AND (“Timor” OR “Atauro”
OR “Oecusse”)); (2) the authors’ own collections of pub-
lished papers and grey literature, which are electronically
indexed, using the same search terms; and (3) the online
repository of rapid assessments of avoidable blindness
(RAABs; http://raabdata.info/repository/), using the single
search term “Timor”. The literature search was done on
9October 2016, andupdated on 28April 2018. Results were
screened for relevance using articles’ titles and abstracts;
where we judged that a paper or report might contain
trachoma prevalence data or case reports, we scrutinized
the full document and extracted pertinent data. For the
most recent RAAB, we were able to draw on the original
dataset, which was accessible to our lead author (MC).
De novo trachoma screening consisted of three sepa-
rate activities. For each of these, the World Health
Organization simplified trachoma grading system11
was generally used as the basis for diagnosis. Where
an ophthalmologist was involved, a more comprehen-
sive clinical evaluation of the eyelid and cornea was also
undertaken.
First, in October 2015, a visiting ophthalmologist
(AJK) systematically examined all available children at
a single school in Vila on Atauro Island (Figure 1),
inspecting the everted upper eyelid of both eyes of each
child, using a head-mounted 2.5 × magnifying loupe and
bright illumination.
Second, all eyecare workers engaged by the East Timor
Eye Program participated in a 1-day training program
covering examination for and recognition of trichiasis,
delivered by a senior registrar in ophthalmology (VA) in
October 2016. Subsequently, from 1 November 2016 to
30 April 2017, those front-line personnel examined for
trichiasis all patients seen as part of routine clinical care in
the referral hospitals of Baucau, Maliana, Suai, Maubisse,
Oecusse and Dili; and the eye clinics of Lospalos (Lautém
District); Viqueque (Viqueque District), Same (Manufahi
District), Ermera (Ermera District) and Atauro Island (Dili
Muncipality) (Figure 1).
Third, to follow up results from the 2016 RAAB, while
undertaking outreach activities to screen for adult catar-
act, three specific communities in Baucau, Cova Lima and
Liquiçá districts (Figure 1) were targeted for focused
house-to-house searches for trachoma. Examinations
were undertaken by ophthalmology registrars (VA,
BMP) from the National Eye Centre. In the three villages,
50, 40 and 20 households, respectively, were visited. The
eyelids of all consenting residents of selected households
were examined.
Ethical considerations
Screening protocols were approved by the Human
Research Ethics Committee, Ministry of Health, Timor-
Leste (GEPS/EP/2014/021). Fieldwork was performed
only after discussion with and verbal approval by rele-
vant village chiefs, heads of local health clinics and the
headmaster of the Atauro Island school. Verbal consent
for examination was provided by each subject or, in the
case of children, by a parent or guardian. Individuals
diagnosed with any eye condition were offered full
diagnostic workup and management, in accordance




The PubMed search returned 108 papers. Only one of
these contained data on the prevalence of trachoma in
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Timor-Leste: a peer-reviewed publication38 describing
the methods and results of the 2016 RAAB. Most of this
information was also included in the RAAB report39
itself, and is therefore presented below.
In the authors’ reference collections, one additional
study of relevance was located, describing a 2012 study
of 293 patients aged 17 years or older presenting to the
National Eye Centre, 80% of whom were residents of
Dili. No cases of TT or active (inflammatory) trachoma
were diagnosed in that series.40
In the RAAB online repository, three RAABs were
listed for Timor-Leste, conducted in 2005,41 2009–201042
and 2016 (Figure 2).39
In the 2005 RAAB, 50 villages were selected using a
probability-proportional-to-village-population-size meth-
odology, drawn equally fromDili and a single rural district,
Bobonaro, 4.5 h by road from Dili. In each village, con-
secutive households were visited until 30 participants aged
≥ 40 years were enrolled. Presenting visual acuity was
measured for each eye of each participant; any eye with
Figure 2. Spatial coverage of the three Timor-Leste rapid assessments of avoidable blindness (RAABs) identified, which were conducted in
2005, 2009–2010 and 2016. The black square shows the capital, Dili. District numbering: 1 = Aileu; 2 = Ainaro; 3 = Baucau; 4 = Bobonaro;
5 = Covalima; 6 = Dili; 7 = Ermera; 8 = Lautém; 9 = Liquiça; 10 = Manatuto; 11 = Manufahi; 12 = Oecussi; 13 = Viqueque.
Figure 1. Spatial coverage of fieldwork conducted as part of this investigation: school screening by a visiting ophthalmologist;
examination by trained eyecare workers of all patients seen for routine clinical care in referral hospital or eye clinic; and house-to-
house case searches by ophthalmology registrars, following up results from the 2016 rapid assessment of avoidable blindness
(RAAB). The black square shows the capital, Dili. District numbering: 2 = Ainaro (sub-district Maubisse); 3 = Baucau; 4 = Bobonaro
(sub-district Maliana); 5 = Covalima; 6 = Dili; 7 = Ermera (sub-district Ermera); 8 = Lautém (sub-district Lospalos); 9 = Liquiça;
11 = Manufahi (sub-district Same); 12 = Oecussi (sub-district Pante Macassar).
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visual acuity worse than 6/18 was further examined to
ascertain the cause of reduced vision. Amongst 1414 people
examined, no cases of trachomatous blindness or low vision
were identified.41
In the 2009–2010 RAAB, from a list of all villages in
the country’s 12 mainland districts, 50 villages were
selected with probability proportional to village popu-
lation size. Some 87% of the population eligible for
selection was rural. In each selected village, consecutive
households were enrolled until 45 participants aged
≥ 40 years were enrolled; in all, 2014 people were
examined. The examination protocol was the same as
that used in 2005. No eyes with trachomatous blindness
or low vision were found.42
In the 2016 RAAB, all 13 districts of Timor-Leste
were included, and 67 villages were selected with prob-
ability proportional to population size.39 Trained teams
examined a total of 3253 participants aged ≥ 50 years.38
Four individuals, in Baucau, Cova Lima, and Liquiçá
districts, were reported to have trachoma, including
one female subject reported to have bilateral trachoma-
tous corneal opacity.38 (During subsequent outreach
work, this individual was identified, re-examined and
found to have ankyloblepharon, without evidence of
trichiasis or entropion.)
De novo trachoma screening
In October 2015, on Atauro, 58 children aged 9–17 years
(mean 11 years) were examined. One 13-year-old male
had unilateral conjunctival scarring of the right upper lid
that had an appearance that would be atypical of tracho-
matous scarring. There were no corneal changes, and no
eyelashes touched the eye. The eyelids of the other 57
children had no signs consistent with trachoma.
Fourteen eyecare workers were trained to recognize
trichiasis and asked to do so as part of their day-to-day
clinical work. The screening protocol required staff to call
the National Eye Centre inDili if any suspected cases were
identified, whereupon one of the visiting Ophthalmology
Fellows would be tasked with driving out to visit patients
in their homes, in order to verify the diagnosis. No calls
were received in the designated 6-month screening per-
iod. To ensure that this was not due to front-line eyecare
personnel forgetting the screening exercise or being
unable to report cases because of pressure of other work,
Fellows and the Head of Department of the National Eye
Centre periodically called eyecare workers to remind
them; on each occasion, assurance was received that tra-
choma was being searched for, and that no suspected
cases had been identified.
In three villages of Baucau, Cova Lima and Liquiçá
in which trachoma was reported to have been identified
in the 2016 RAAB, no cases of trichiasis, trachomatous
conjunctival scarring or active trachoma were found.
Discussion
Though much work remains, tremendous progress is
currently being made against trachoma globally.43,44
We undertook the studies described in this manuscript
because it was not clear whether trachoma was likely to
be a public health problem in Timor-Leste, and we did
not want its people to be left behind. We used an
approach consistent with the logic used for justifying
mapping or not mapping within the Global Trachoma
Mapping Project.14 Documenting the methodology and
outcome of our work is, we think, important, to avoid
duplication of effort and, assuming that others agree
with our conclusion, to prevent continuing uncertainty
over the possibility of a trachoma elimination program
being required here.
With a predominantly rural population—almost two
thirds of residents live in areas considered to be remote
—and an under-resourced health service, there are mul-
tiple barriers to accessing eye care in Timor-Leste.45,46
We could not necessarily assume that individuals suffer-
ing from trichiasis would present to clinics requesting
assistance for that problem. We therefore systematically
searched for evidence of trichiasis in the published lit-
erature on Timor-Leste, in individuals attending eye care
facilities with any presenting complaint, and in samples
drawn from communities believed (on the basis of pre-
vious reports) to be at high risk.
In the three RAABs that we identified38,41,42 investiga-
tors assessed the anterior segment of an examinee’s eye,
including for corneal opacity, only if the eye had low
vision: the presence of trichiasis in an eye with normal
presenting vision would not have been recorded. The
previously-published study conducted at the National
Eye Centre40 entailed a comprehensive ophthalmic exam-
ination of each patient by an eye specialist, but only 57 of
293 subjects included were residents of rural areas, where
trachoma ismore likely to be found.33,47,48 Our systematic
clinic-based screening exercise provided far greater geo-
graphical coverage. We visited the culturally-distinct, for-
mer prison island of Atauro, where water, sanitation, and
other infrastructure are below average national standards,
to look for trachoma in the conjunctivae of local school-
children. Prompted by reports of trichiasis being found in
individuals sampled within the 2016 RAAB, we also
undertook active screening of residents of all ages in
three purposively-selected rural communities. We found
no evidence of trachoma in any individual examined.
These investigations had someweaknesses. First, RAABs
do not involve the examination of children and do not
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include eyelid eversion, even if vision is < 6/18 in the better
eye. They therefore have poor sensitivity for determining
whether trachoma is present as a public health
problem. Second, the de novo screening that we undertook
was somewhat limited in scope, concentrating particularly
on individuals self-presenting to eye care services, with the
only fieldwork undertaken being the visit to Atauro and
a follow-up of three communities identified by the 2016
RAAB as possibly having residents with trichiasis. All chil-
dren examined on Atauro in October 2015 were aged
9 years or above; active trachoma is much more usually
found in pre-school-age than older children,49–51 but in
areas of intense transmission, conjunctival scarring can be
seen in 9–17-year-olds, as examined here.52 Unfortunately,
we did not have the human resource capacity to also under-
take community-based screening of younger children dur-
ing the visit to Atauro. Third, no formal standardization
(through inter-grader agreement exercises or objective
structured clinical examination53–55) of the graders who
participated in our trachoma screening exercises was
undertaken. Fourth, house-to-house surveys, as used in
three communities in this series of investigations, will result
in under-representation of working adults and school-
going children. The latter are, however, less likely to have
trachoma than 1–9-year-olds examined as part of commu-
nity-based surveys.56 Finally, some authorities advocate the
use of the key informant method57 as the best method for
identifying blinding eye conditions; we did not use this
technique.
Despite these limitations, having failed to find a single
case of trichiasis amongst all-comers to eye care services
nation-wide over a continuous period of observation of 6
months, and having been unable to substantiate previous
case reports of trachoma or find others with evidence of
disease in the same communities, we suggest that tra-
choma is very unlikely to represent a current public
health problem in Timor-Leste. Given that only 41% of
the population accesses improved sanitation facilities,34
continued vigilance for the emergence of trachoma will
be necessary until such time as living standards improve.
Disclosure Statement
The authors report no conflicts of interest. The authors alone
are responsible for the content and writing of the paper.
Funding
This work was undertaken by the East Timor Eye Program
(ETEP; https://www.etep.org.au/), which has supported the
delivery of specialist eye care services and capacity building of
eye care personnel in the country since 2000, and by the
National Eye Centre, which opened in July 2012 with support
from the Timorese Ministry of Health, the Australian
Government, the Fred Hollows Foundation and ETEP.
ETEP receives support from the Royal Australasian College
of Surgeons. AWS is a staff member of the World Health
Organization. The authors alone are responsible for the views
expressed in this article and they do not necessarily represent
the views, decisions or policies of the institutions with which
they are affiliated. None of the funders had any role in project
design, in project implementation or analysis or interpreta-
tion of data, in the decisions on where, how or when to
publish in the peer reviewed press, or in preparation of the
manuscript.
References
1. Solomon AW, Mabey DC. Modeling the economic net
benefit of a potential vaccination program against ocular
infection with Chlamydia trachomatis. Vaccine. 2005;23
(46–47):5281–5282. doi:10.1016/j.vaccine.2005.05.042.
2. Poston TB, Gottlieb SL, Darville T. Status of vaccine
research and development of vaccines for Chlamydia
trachomatis infection. Vaccine. 2017. [Epub ahead of
print]. doi:10.1016/j.vaccine.2017.01.023.
3. Mabey DC, Solomon AW, Foster A. Trachoma. Lancet.
2003;362(9379):223–229. doi:10.1016/S0140-6736(03)
13914-1.
4. Francis V, Turner V. Achieving Community Support for
Trachoma Control (WHO/PBL/93.36). Geneva: World
Health Organization; 1993.
5. Burton M, Habtamu E, Ho D, Gower EW. Interventions
for trachoma trichiasis. Cochrane Database Syst Rev.
2015;11:CD004008.
6. Evans JR, Solomon AW. Antibiotics for trachoma.
Cochrane Database Syst Rev. 2011;3:CD001860.
7. Ejere HO, Alhassan MB, Rabiu M. Face washing pro-
motion for preventing active trachoma. Cochrane
Database Syst Rev. 2015;2:CD003659.
8. Rabiu M, Alhassan MB, Ejere HO, Evans JR.
Environmental sanitary interventions for preventing
active trachoma. Cochrane Database Syst Rev. 2012;
(2):CD004003. DOI: 10.1002/14651858.CD004003.
pub4. Available from: http://tropicaldata.knowledge
owl.com/help/training-system-for-trachoma-
prevalence-surveys
9. Solomon AW, Zondervan M, Kuper H, Buchan JC,
Mabey DCW, Foster A. Trachoma Control: A Guide
for Programme Managers. Geneva: World Health
Organization; 2006.
10. Ngondi J, Reacher M, Matthews F, Brayne C,
Emerson P. Trachoma survey methods: a literature
review. Bull World Health Organ. 2009;87:143–151.
11. Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR.
A simple system for the assessment of trachoma and its
complications. BullWorld Health Organ. 1987;65:477–483.
12. Trotignon G, Jones E, Engels T, et al. The cost of
mapping trachoma: data from the Global Trachoma
Mapping Project. PLoS Negl Trop Dis. 2017;11(10):
e0006023. doi:10.1371/journal.pntd.0006023.
13. Chen C, Cromwell EA, King JD, et al. Incremental cost
of conducting population-based prevalence surveys for
a neglected tropical disease: the example of trachoma
OPHTHALMIC EPIDEMIOLOGY 135
in 8 national programs. PLoS Negl Trop Dis. 2011;5(3):
e979. doi:10.1371/journal.pntd.0001370.
14. Solomon AW, Willis R, Pavluck AL, et al. Quality
assurance and quality control in the Global Trachoma
Mapping Project. Am J Trop Med Hyg. 2018; 99
(4):858–863. doi:10.4269/ajtmh.18-0082.
15. Malhotra S, Vashist P, Gupta N, et al. Prevalence of
trachoma inCar-Nicobar Island, India after Three annual
rounds of mass drug administration with Azithromycin.
PLoS One. 2016;11(7):e0158625. doi:10.1371/journal.
pone.0158625.
16. Ko R, Macleod C, Pahau D, et al. Population-based tra-
choma mapping in six evaluation units of Papua New
Guinea. Ophthalmic Epidemiol. 2016;23(Sup1):22–31.
doi:10.1080/09286586.2016.1235715.
17. Meng N, Seiha D, Thorn P, et al. Assessment of tra-
choma in Cambodia: trachoma is not a public health
problem. Ophthalmic Epidemiol. 2016;23(Sup1):3–7.
doi:10.1080/09286586.2016.1230223.
18. Sokana O,Macleod C, Jack K, et al. Mapping trachoma in
the Solomon Islands: results of three baseline
population-based prevalence surveys conducted with
the Global Trachoma Mapping Project. Ophthalmic
Epidemiol. 2016;23(Sup1):15–21. doi:10.1080/09286586.
2016.1238946.
19. Southisombath K, Sisalermsak S, Chansan P, et al.
National trachoma assessment in the Lao people’s
democratic republic in 2013-2014. Ophthalmic
Epidemiol. 2016;23(Sup1):8–14. doi:10.1080/092865
86.2016.1236973.
20. Cama A, Müller A, Taoaba R, et al. Prevalence of signs
of trachoma, ocular Chlamydia trachomatis infection
and antibodies to Pgp3 in residents of Kiritimati
Island, Kiribati. PLoS Negl Trop Dis. 2017;11(9):
e0005863. doi:10.1371/journal.pntd.0005863.
21. Taleo F, Macleod CK, Marks M, et al. Integrated map-
ping of Yaws and Trachoma in the five Northern-most
provinces of Vanuatu. PLoS Negl Trop Dis. 2017;11(1):
e0005267. doi:10.1371/journal.pntd.0005267.
22. Hiep NX, Ngondi JM, Anh VT, et al. Trachoma in Viet
Nam: results of 11 surveillance surveys conducted with
the Global Trachoma Mapping Project. Ophthalmic
Epidemiol. 2018. In press
23. Macleod CK, Butcher R, Mudaliar U, et al. Low pre-
valence of ocular chlamydia trachomatis infection and
active trachoma in the Western Division of Fiji. PLoS
Negl Trop Dis. 2016;10(7):e0004798. doi:10.1371/jour-
nal.pntd.0004798.
24. Dirani M, Keel S, Foreman J, van Wijngaarden P,
Taylor HR. Prevalence of trachomatous trichiasis in
Australia: the National Eye Health Survey. Clin Exp
Ophthalmol. 2017;46(1):13–17. doi:10.1111/ceo.13003.
25. Butcher RM, Sokana O, Jack K, et al. Low prevalence of
conjunctival infection with chlamydia trachomatis in a
treatment-naive trachoma-endemic region of the
Solomon Islands. PLoS Negl Trop Dis. 2016;10(9):
e0004863. doi:10.1371/journal.pntd.0004863.
26. Cocks N, Rainima-Qaniuci M, Yalen C, et al.
Community seroprevalence survey for yaws and tra-
choma in the Western Division of Fiji. Trans R Soc
Trop Med Hyg. 2016;110(10):582–587. doi:10.1093/
trstmh/trw069.
27. Macleod C, Yalen C, Butcher R, et al. Eyelash epilation
in the absence of trichiasis: results of a population-based
prevalence Survey in the Western Division of Fiji. PLoS
Negl Trop Dis. 2017;11(1):e0005277. doi:10.1371/journal.
pntd.0005277.
28. Butcher R, Sokana O, Jack K, et al. Clinical signs of
trachoma are prevalent among Solomon Islanders who
have no persistent markers of prior infection with
Chlamydia trachomatis. Wellcome Open Res. 2018;3:14.
doi:10.12688/wellcomeopenres.13423.2.
29. Butcher RMR, Sokana O, Jack K, et al. Active trachoma
cases in the Solomon Islands have varied polymicrobial
community structures but do not associate with indi-
vidual non-chlamydial pathogens of the eye. Front
Med. 2018;4:251. doi:10.3389/fmed.2017.00251.
30. Polack SR, Solomon AW, Alexander ND, et al. The
household distribution of trachoma in a Tanzanian vil-
lage: an application of GIS to the study of trachoma.
Trans R Soc Trop Med Hyg. 2005;99(3):218–225.
doi:10.1016/j.trstmh.2004.06.010.
31. Bailey R, Osmond C, Mabey DC, Whittle HC,
Ward ME. Analysis of the household distribution of
trachoma in a Gambian village using a Monte Carlo
simulation procedure. Int J Epidemiol. 1989;18:944–951.
32. Smith JL, Flueckiger RM, Hooper PJ, et al. The geogra-
phical distribution and burden of trachoma in Africa.
PLoS Negl Trop Dis. 2013;7(8):e2359. doi:10.1371/jour-
nal.pntd.0002359.
33. Smith JL, Sivasubramaniam S, Rabiu MM, Kyari F,
Solomon AW, Gilbert C. Multilevel analysis of tracho-
matous trichiasis and corneal opacity in Nigeria: the
role of environmental and climatic risk factors on the
distribution of disease. PLoS Negl Trop
Dis. 2015;9(7):e0003826. doi:10.1371/journal.pntd.000
3826.
34. UNICEF, World Health Organization. Progress on
Sanitation and Drinking Water: 2015 Update and
MDG Assessment. Geneva: UNICEF and World
Health Organization; 2015.
35. Garn JV, Boisson S, Willis R, et al. Sanitation and water
supply coverage thresholds associated with active tra-
choma: modeling cross-sectional data from 13 countries.
PLoS Negl Trop Dis. 2018;12(1):e0006110. doi:10.1371/
journal.pntd.0006110.
36. Solomon AW, Kurylo E. The global trachoma mapping
project. Community Eye Health. 2014;27:18.
37. World Health Assembly. Global Elimination of
Blinding Trachoma. 51st World Health Assembly,
Geneva, 16 May 1998, Resolution WHA51.11. Geneva:
World Health Organization; 1998.
38. Correia M, Das T, Magno J, et al. Prevalence and causes
of blindness, visual impairment, and cataract surgery in
Timor-Leste. Clin Ophthalmol. 2017;11:2125–2131.
doi:10.2147/OPTH.S146901.
39. Ministry of Health. Summary Report: Rapid Assessment
of Avoidable Blindness, Timor-Leste. Dili: Ministry of
Health, Timor-Leste; 2017; 2016.
40. Sugnanam KK, Ma S, Kreis A, Correia M, Verma N,
Dirani M. Prospective study of eye disease in
Timor-Leste: the east timor eye program. Asia Pac
J Ophthalmol (Phila). 2016;5(5):349–353. doi:10.1097/
APO.0000000000000164.
136 M. CORREIA ET AL.
41. Ramke J, Palagyi A, Naduvilath T, et al., Prevalence
and causes of blindness and low vision in Timor-Leste.
Br J Ophthalmol. 2007;91(9):1117–1121. doi:10.1136/
bjo.2006.106559.
42. Ramke J, Brian G, Naduvilath T, Lee L,
Qoqonokana MQ. Prevalence and causes of blindness
and low vision revisited after 5 years of eye care in
Timor-Leste. Ophthalmic Epidemiol. 2012;19(2):52–57.
doi:10.3109/09286586.2011.645108.
43. World Health Organization. WHO alliance for the
global elimination of trachoma by 2020: progress
report on elimination of trachoma, 2014-2016. Wkly
Epidemiol Rec. 2017;92(26): 359–368.
44. Solomon AW, Emerson PM, Resnikoff S. Trachoma
then and now: update on mapping and control.
Community Eye Health. 2017;30:90–91.
45. Lee L, Ramke J, Blignault I, Casson RJ. Changing
barriers to use of eye care services in Timor-Leste:
2005 to 2010. Ophthalmic Epidemiol. 2013;20
(1):45–51. doi:10.3109/09286586.2012.742551.
46. Palagyi A, Ramke J, du Toit R, et al., Eye care in
Timor-Leste: a population-based study of utilization
and barriers. Clin Exp Ophthalmol. 2008;36(1):47–53.
doi:10.1111/j.1442-9071.2007.01645.x.
47. Sallam TA, Raja’a YA, Al-Zubiery TK, et al. Chlamydia
trachomatis infections among Yemeni school pupils in
relation to environmental conditions. Saudi Med J.
2003;24(1):84–87.
48. Berhane Y, Worku A, Bejiga A, et al. Prevalence of
trachoma in Ethiopia. Ethiop J Health Dev. 2007;21
(3):211–215.
49. Bero B, Macleod C, Alemayehu W, et al. Prevalence of
and risk factors for trachoma in Oromia regional state
of Ethiopia: results of 79 population-based prevalence
surveys conducted with the Global Trachoma Mapping
Project. Ophthalmic Epidemiol. 2016;23(6):392–405.
doi:10.1080/09286586.2016.1243717.
50. Elshafie BE, Osman KH, Macleod C, et al. The epide-
miology of trachoma in Darfur states and Khartoum
state, Sudan: results of 32 population-based prevalence
surveys. Ophthalmic Epidemiol. 2016;23(6):381–391.
doi:10.1080/09286586.2016.1243718.
51. Adera TH, Macleod C, Endriyas M, et al. Prevalence
of and risk factors for trachoma in Southern Nations,
nationalities, and peoples’ region, Ethiopia: results of
40 Population-based prevalence surveys carried out
with the Global Trachoma Mapping Project.
Ophthalmic Epidemiol. 2016;23(Sup1):84–93. doi:10.
1080/09286586.2016.1247876.
52. West SK, Munoz B, Mkocha H, Hsieh YH, Lynch MC.
Progression of active trachoma to scarring in a cohort
of Tanzanian children. Ophthalmic Epidemiol.
2001;8:137–144.
53. Courtright P, MacArthur C, Macleod C, et al. Tropical
data: training system for trachoma prevalence surveys
(version 1). London: International Coalition for
Trachoma Control; 2016. http://tropicaldata.knowledge
owl.com/help/training-system-for-trachoma-
prevalence-surveys, Accessed August 30, 2017.
54. Solomon AW, Pavluck A, Courtright P, et al. The
Global Trachoma Mapping Project: methodology of a
34-country population-based study. Ophthalmic
Epidemiol. 2015;22(3):214–225. doi:10.3109/
09286586.2015.1037401.
55. World Health Organization Strategic and Technical
Advisory Group on Neglected Tropical Diseases.
Design and Validation of a Trachomatous Trichiasis-
Only Survey (WHO/HTM/NTD/PCT/2017.08). Geneva:
World Health Organization; 2018.
56. King JD, Odermatt P, Utzinger J, et al. Trachoma
among children in community surveys from four
African countries and implications of using school
surveys for evaluating prevalence. Int Health. 2013;5
(4):280–287. doi:10.1093/inthealth/iht027.
57. Muhit MA, Shah SP, Gilbert CE, Hartley SD, Foster A.
The key informant method: a novel means of ascertain-
ing blind children in Bangladesh. Br J Ophthalmol.
2007;91(8):995–999. doi:10.1136/bjo.2006.108027.
OPHTHALMIC EPIDEMIOLOGY 137
